‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
How to save a life with naloxone
By providing non-judgemental and appropriate counselling on the use of naloxone, pharmacists can empower those who carry it to confidently intervene in the case of opioid toxicity.
Could this medicine revolutionise schizophrenia treatment?
Working on a new mechanism of action, this treatment could change the lives of patients with schizophrenia. But not all patients can take it.
Stepping down safely: deprescribing gabapentinoids in practice
Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.
Government pulls the plug on replica Ozempic
After much media scrutiny, the federal Department of Health and Aged Care has announced a ban on compounded GLP-1RAs.
Efficacy and safety of diclofenac for the management of pain
Pharmacists are well equipped to assist patients who request treatment for pain. This article discusses the role of the pharmacist in the appropriate supply of over-the-counter diclofenac for management of pain.
Making antidepressant tapering safer and easier
In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.
